List of Excipients in API acyclovir
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing acyclovir
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA Inc | ACYCLOVIR | acyclovir | 0093-3630 | CETOSTEARYL ALCOHOL | |
| Teva Pharmaceuticals USA Inc | ACYCLOVIR | acyclovir | 0093-3630 | MINERAL OIL | |
| Teva Pharmaceuticals USA Inc | ACYCLOVIR | acyclovir | 0093-3630 | PETROLATUM | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing acyclovir
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 | POLYETHYLENE GLYCOL |
| Mylan Pharmaceuticals Inc | acyclovir | 0378-8700 | POLYETHYLENE GLYCOL |
| Liberty Pharmaceuticals Inc | acyclovir | 0440-7033 | CELLULOSE, MICROCRYSTALLINE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for acyclovir
Excipient focus: ALCOHOL
acyclovir drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | acyclovir | 0904-5789 |
| AvKARE | acyclovir | 42291-017 |
| PD-Rx Pharmaceuticals Inc | acyclovir | 43063-826 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALUMINUM OXIDE
acyclovir drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Apotheca Inc | acyclovir | 12634-520 |
| QPharma Inc | acyclovir | 42708-073 |
| Bryant Ranch Prepack | acyclovir | 63629-1677 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
acyclovir drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | acyclovir | 0904-5789 |
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | acyclovir | 23155-229 |
| AvKARE | acyclovir | 42291-017 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: BANANA
acyclovir drug variants containing BANANA
| Company | Ingredient | NDC |
|---|---|---|
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | acyclovir | 23155-485 |
| Akorn | acyclovir | 50383-810 |
| Aurobindo Pharma Limited | acyclovir | 59651-493 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing BANANA
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: BROWN IRON OXIDE
acyclovir drug variants containing BROWN IRON OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | acyclovir | 50090-5610 |
| Lake Erie Medical DBA Quality Care Products LLC | acyclovir | 55700-651 |
| RedPharm Drug Inc | acyclovir | 67296-1543 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing BROWN IRON OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
acyclovir drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | acyclovir | 0904-5789 |
| AvKARE | acyclovir | 42291-017 |
| PD-Rx Pharmaceuticals Inc | acyclovir | 43063-826 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
acyclovir drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | acyclovir | 0378-8712 |
| Mylan Pharmaceuticals Inc | acyclovir | 0378-9735 |
| Actavis Pharma Inc | acyclovir | 0472-0082 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
acyclovir drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | acyclovir | 0378-8712 |
| Mylan Pharmaceuticals Inc | acyclovir | 0378-9735 |
| Liberty Pharmaceuticals Inc | acyclovir | 0440-7033 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: CETOSTEARYL ALCOHOL
acyclovir drug variants containing CETOSTEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| Bausch Health US LLC | acyclovir | 0187-0994 |
| Bausch Health US LLC | acyclovir and hydrocortisone | 0187-5104 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing CETOSTEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| Mylan Pharmaceuticals Inc | acyclovir | 0378-8700 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
acyclovir drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | acyclovir and hydrocortisone | 0187-5104 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: COLLOIDAL SILICON DIOXIDE
acyclovir drug variants containing COLLOIDAL SILICON DIOXIDE
acyclovir drug variants not containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
acyclovir drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Liberty Pharmaceuticals Inc | acyclovir | 0440-7033 |
| Major Pharmaceuticals | acyclovir | 0904-5789 |
| Major Pharmaceuticals | acyclovir | 0904-5790 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
acyclovir drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Preferred Pharmaceuticals Inc | acyclovir | 68788-7576 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 28
acyclovir drug variants containing D&C RED NO. 28
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | acyclovir | 10544-101 |
| Aidarex Pharmaceuticals LLC | acyclovir | 33261-419 |
| HJ Harkins Company Inc | acyclovir | 52959-517 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing D&C RED NO. 28
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 33
acyclovir drug variants containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | acyclovir | 10544-101 |
| Aidarex Pharmaceuticals LLC | acyclovir | 33261-419 |
| HJ Harkins Company Inc | acyclovir | 52959-517 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
acyclovir drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | acyclovir | 10544-101 |
| Aidarex Pharmaceuticals LLC | acyclovir | 33261-419 |
| A-S Medication Solutions | acyclovir | 50090-5610 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
acyclovir drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | acyclovir | 0904-5789 |
| Blenheim Pharmacal Inc | acyclovir | 10544-101 |
| Aidarex Pharmaceuticals LLC | acyclovir | 33261-419 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
acyclovir drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | acyclovir | 10544-101 |
| Blenheim Pharmacal Inc | acyclovir | 10544-102 |
| Apotheca Inc | acyclovir | 12634-520 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 3
acyclovir drug variants containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | acyclovir | 50090-7216 |
| Northwind Pharmaceuticals LLC | acyclovir | 51655-965 |
| RPK Pharmaceuticals Inc | acyclovir | 53002-2452 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
acyclovir drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | acyclovir | 10544-101 |
| Aidarex Pharmaceuticals LLC | acyclovir | 33261-419 |
| A-S Medication Solutions | acyclovir | 50090-5610 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
acyclovir drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | acyclovir | 62135-039 |
| YILING PHARMACEUTICAL INC | acyclovir | 69117-0039 |
| EMC PHARMA LLC | acyclovir | 81288-039 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
acyclovir drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | acyclovir | 31722-777 |
| PD-Rx Pharmaceuticals Inc | acyclovir | 43063-928 |
| A-S Medication Solutions | acyclovir | 50090-1567 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
acyclovir drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | acyclovir | 0904-5789 |
| Blenheim Pharmacal Inc | acyclovir | 10544-089 |
| Rebel Distributors Corp | acyclovir | 21695-009 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
acyclovir drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | acyclovir | 0904-5789 |
| Blenheim Pharmacal Inc | acyclovir | 10544-089 |
| Blenheim Pharmacal Inc | acyclovir | 10544-101 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
acyclovir drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | acyclovir | 0378-8712 |
| Mylan Pharmaceuticals Inc | acyclovir | 0378-9735 |
| Actavis Pharma Inc | acyclovir | 0472-0082 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
acyclovir drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | acyclovir and hydrocortisone | 0187-5104 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2208
acyclovir drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Cipher Pharmaceuticals US LLC | acyclovir | 68712-049 |
| EPI Health Inc | acyclovir | 71403-049 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: INDIGOTINDISULFONATE SODIUM
acyclovir drug variants containing INDIGOTINDISULFONATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Proficient Rx LP | acyclovir | 63187-154 |
| Bryant Ranch Prepack | acyclovir | 63629-7001 |
| RedPharm Drug Inc | acyclovir | 67296-0240 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing INDIGOTINDISULFONATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
acyclovir drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | acyclovir | 0904-5789 |
| AvKARE | acyclovir | 42291-017 |
| PD-Rx Pharmaceuticals Inc | acyclovir | 43063-826 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL MYRISTATE
acyclovir drug variants containing ISOPROPYL MYRISTATE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | acyclovir and hydrocortisone | 0187-5104 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing ISOPROPYL MYRISTATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
acyclovir drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | acyclovir | 10544-089 |
| Blenheim Pharmacal Inc | acyclovir | 10544-101 |
| Blenheim Pharmacal Inc | acyclovir | 10544-102 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
acyclovir drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Liberty Pharmaceuticals Inc | acyclovir | 0440-7033 |
| Major Pharmaceuticals | acyclovir | 0904-5789 |
| Major Pharmaceuticals | acyclovir | 0904-5790 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
acyclovir drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | acyclovir | 0378-8712 |
| Mylan Pharmaceuticals Inc | acyclovir | 0378-9735 |
| Actavis Pharma Inc | acyclovir | 0472-0082 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: MINERAL OIL
acyclovir drug variants containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| Bausch Health US LLC | acyclovir | 0187-0994 |
| Rebel Distributors Corp | acyclovir | 42254-149 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| Mylan Pharmaceuticals Inc | acyclovir | 0378-8700 |
| >Company | >Ingredient | >NDC |
Excipient focus: NONCRYSTALLIZING SORBITOL SOLUTION
acyclovir drug variants containing NONCRYSTALLIZING SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | acyclovir | 31722-681 |
| Aurobindo Pharma Limited | acyclovir | 59651-493 |
| Chartwell RX LLC | acyclovir | 62135-803 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing NONCRYSTALLIZING SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: PETROLATUM
acyclovir drug variants containing PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| Bausch Health US LLC | acyclovir | 0187-0994 |
| Rebel Distributors Corp | acyclovir | 42254-149 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| Mylan Pharmaceuticals Inc | acyclovir | 0378-8700 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 188
acyclovir drug variants containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | acyclovir and hydrocortisone | 0187-5104 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 407
acyclovir drug variants containing POLOXAMER 407
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| Bausch Health US LLC | acyclovir | 0187-0994 |
| Rebel Distributors Corp | acyclovir | 42254-149 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing POLOXAMER 407
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| Mylan Pharmaceuticals Inc | acyclovir | 0378-8700 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
acyclovir drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| Mylan Pharmaceuticals Inc | acyclovir | 0378-8700 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| Bausch Health US LLC | acyclovir | 0187-0994 |
| Mylan Pharmaceuticals Inc | acyclovir | 0378-8712 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 1450
acyclovir drug variants containing POLYETHYLENE GLYCOL 1450
| Company | Ingredient | NDC |
|---|---|---|
| Solco Healthcare US LLC | acyclovir | 43547-499 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing POLYETHYLENE GLYCOL 1450
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 300
acyclovir drug variants containing POLYETHYLENE GLYCOL 300
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | acyclovir | 13668-515 |
| Solco Healthcare US LLC | acyclovir | 43547-499 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing POLYETHYLENE GLYCOL 300
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
acyclovir drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | acyclovir | 0904-5789 |
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | acyclovir | 23155-229 |
| AvKARE | acyclovir | 42291-017 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
acyclovir drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | acyclovir | 10544-102 |
| Blenheim Pharmacal Inc | acyclovir | 10544-103 |
| Camber Pharmaceuticals Inc | acyclovir | 31722-777 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K25
acyclovir drug variants containing POVIDONE K25
| Company | Ingredient | NDC |
|---|---|---|
| Apotheca Inc | acyclovir | 12634-520 |
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | acyclovir | 23155-227 |
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | acyclovir | 23155-229 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing POVIDONE K25
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
acyclovir drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | acyclovir | 50090-6335 |
| A-S Medication Solutions | acyclovir | 50090-6578 |
| RPK Pharmaceuticals Inc | acyclovir | 53002-0083 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONES
acyclovir drug variants containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | acyclovir | 53808-0609 |
| MedVantx Inc | acyclovir | 66116-414 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
acyclovir drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| Bausch Health US LLC | acyclovir | 0187-0994 |
| Major Pharmaceuticals | acyclovir | 0904-5789 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| Mylan Pharmaceuticals Inc | acyclovir | 0378-8700 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
acyclovir drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | acyclovir | 0378-8712 |
| Mylan Pharmaceuticals Inc | acyclovir | 0378-9735 |
| Actavis Pharma Inc | acyclovir | 0472-0082 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
acyclovir drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | acyclovir | 0904-5789 |
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | acyclovir | 23155-229 |
| AvKARE | acyclovir | 42291-017 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
acyclovir drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Liberty Pharmaceuticals Inc | acyclovir | 0440-7033 |
| Major Pharmaceuticals | acyclovir | 0904-5789 |
| Major Pharmaceuticals | acyclovir | 0904-5790 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
acyclovir drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals (USA) Inc | acyclovir | 68382-048 |
| Zydus Pharmaceuticals USA Inc | acyclovir | 68382-125 |
| Zydus Lifesciences Limited | acyclovir | 70771-1081 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURETH SULFATE
acyclovir drug variants containing SODIUM LAURETH SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Carlsbad Technology Inc | acyclovir | 61442-111 |
| RedPharm Drug Inc | acyclovir | 67296-0656 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing SODIUM LAURETH SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURETH-3 SULFATE
acyclovir drug variants containing SODIUM LAURETH-3 SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | acyclovir | 50090-0596 |
| Proficient Rx LP | acyclovir | 63187-182 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing SODIUM LAURETH-3 SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
acyclovir drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| Bausch Health US LLC | acyclovir | 0187-0994 |
| Blenheim Pharmacal Inc | acyclovir | 10544-101 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| Mylan Pharmaceuticals Inc | acyclovir | 0378-8700 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
acyclovir drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | acyclovir | 10544-102 |
| Blenheim Pharmacal Inc | acyclovir | 10544-103 |
| Apotheca Inc | acyclovir | 12634-520 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
acyclovir drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | acyclovir | 0378-8712 |
| Mylan Pharmaceuticals Inc | acyclovir | 0378-9735 |
| Actavis Pharma Inc | acyclovir | 0472-0082 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL SOLUTION
acyclovir drug variants containing SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| Novadoz Pharmaceuticals LLC | acyclovir | 72205-170 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
acyclovir drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Blenheim Pharmacal Inc | acyclovir | 10544-089 |
| Blenheim Pharmacal Inc | acyclovir | 10544-101 |
| Apotheca Inc | acyclovir | 12634-520 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, PREGELATINIZED CORN
acyclovir drug variants containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | acyclovir | 53217-188 |
| Lake Erie Medical DBA Quality Care Products LLC | acyclovir | 55700-664 |
| NuCare PharmaceuticalsInc | acyclovir | 66267-007 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
acyclovir drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| RPK Pharmaceuticals Inc | acyclovir | 53002-0080 |
| RPK Pharmaceuticals Inc | acyclovir | 53002-0081 |
| RedPharm Drug Inc | acyclovir | 67296-1625 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
acyclovir drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | acyclovir | 0904-5789 |
| Blenheim Pharmacal Inc | acyclovir | 10544-089 |
| Blenheim Pharmacal Inc | acyclovir | 10544-101 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
acyclovir drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | acyclovir | 0093-3630 |
| Bausch Health US LLC | acyclovir | 0187-0994 |
| Actavis Pharma Inc | acyclovir | 0472-0082 |
| >Company | >Ingredient | >NDC |
acyclovir drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | acyclovir | 0168-0825 |
| Bausch Health US LLC | acyclovir | 0187-0993 |
| Mylan Pharmaceuticals Inc | acyclovir | 0378-8700 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
